Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Docetaxel/oxaliplatin"'
Autor:
Yukinori Kurokawa, Tomono Kawase, Atsushi Takeno, Haruna Furukawa, Ryo Yoshioka, Takuro Saito, Tsuyoshi Takahashi, Toshio Shimokawa, Hidetoshi Eguchi, Yuichiro Doki
Publikováno v:
Annals of Gastroenterological Surgery, Vol 7, Iss 2, Pp 247-254 (2023)
Abstract Background Although perioperative treatment has been the standard of care for resectable gastric cancer in the West, postoperative adjuvant chemotherapy is still the standard in Japan. We conducted the first phase 2 trial to investigate the
Externí odkaz:
https://doaj.org/article/c3a68a992cae43c4bcdbea733a506cf4
Autor:
Jong Seok Lee, Myeong-Cherl Kook, Jong Gwang Kim, Young Soo Park, Nam Su Lee, Dae Young Zang, Inho Kim, Jeong Hwan Yook, Sun Young Rha, Cho-Hyun Park, Seung Hoon Beom, You Jin Jang, Young-Kyu Park, Sang-Hee Cho, Taeil Son, Sung Hoon Noh, Chang Hak Yoo, Hyunki Kim, Moon-Won Yoo, Ik Joo Chung, Jin-Hyuk Choi, Sang Ho Lee, Yeonju Lee, Baek-Yeol Ryoo, Sang Cheul Oh, Gyunji Kim, Jee Hyun Lee, Yoon-Koo Kang, Beom Su Kim, Jin Young Kim, Mi Hwa Heo, Min-Hee Ryu, Ji Young Sul, Mi Ran Jung, Young-Woo Kim, Hark Kyun Kim, Seung Wan Ryu
Publikováno v:
Journal of Clinical Oncology. 39:2903-2913
PURPOSE Adjuvant chemotherapy after D2 gastrectomy is standard for resectable locally advanced gastric cancer (LAGC) in Asia. Based on positive findings for perioperative chemotherapy in European phase III studies, the phase III PRODIGY study (Clinic
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ferit Aslan, Umut Demirci, Erkan Erdur, Gulnihal Tufan, Nazan Demir, Ayse Durnali, Fatih Yildiz, Hacer Demir, Berna Oksuzoglu, Aysegul Ilhan, Emre Eraslan, Ozgen Ahmet Yildirim, Hüseyin Kanmaz
Publikováno v:
International Journal of Hematology and Oncology. 30:155-161
Autor:
Yachiyo Kuwatsuka, Norofumi Hattori, Kenta Murotani, Kazushi Miyata, Yoshikuni Inokawa, Mitsuro Kanda, Tomoki Ebata, Chie Tanaka, Masamichi Hayashi, Dai Shimizu, Osamu Maeda, Masahiko Koike, Goro Nakayama, Yasuhiro Kodera, Masahiko Ando, Yuichi Ando
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 24, Iss, Pp 100853-(2021)
Contemporary Clinical Trials Communications, Vol 24, Iss, Pp 100853-(2021)
In Japan, esophagectomy after two courses of 5-fluorouracil plus cisplatin is regarded a standard strategy for treating resectable stage II or III esophageal squamous cell carcinoma (ESCC). However, 5-fluorouracil plus cisplatin does not benefit coho
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39(34)
Autor:
Zhenxin Zhu, Peng Wang, Qingping Cai, Yu Zhang, Huang Xin, Ronglin Yan, Zunqi Hu, Hejing Huang, Dejun Yang, Xin Zhang
Publikováno v:
Technology in Cancer Research & Treatment
Technology in Cancer Research & Treatment, Vol 20 (2021)
Technology in Cancer Research & Treatment, Vol 20 (2021)
Background: The optimal treatment for gastric cancer with peritoneal metastasis (GCPM) remains debatable. This study aimed to compare the efficacy and safety of neoadjuvant intraperitoneal and systemic chemotherapy (NIPS) versus neoadjuvant systemic
Autor:
Laura Woodhouse, Valentinos Kounnis, Konstantinos Kamposioras, Jamie M J Weaver, Brindley Sonal Hapuarachi, Neethu Billy Graham Mariam, Wasat Mansoor, Rebecca Lee, Richard A Hubner, Fiona Britton, Thomas K. Waddell, Adeel M Khan, Kathleen Connors, Jessica Coyle
Publikováno v:
Journal of Clinical Oncology. 39:4039-4039
4039 Background: Despite potentially curative surgery, long-term survival from OGC remains poor due to high relapse rate. Neoadjuvant (naFLOT) and adjuvant (aFLOT) FLOT is currently standard treatment for resectable OGC based on data from the FLOT-4
Autor:
Hüseyin Engin, G. Çevik
Publikováno v:
Annals of Oncology. 31:S204
Autor:
Praveen Garg, Pankaj Baweja, S. Valame, Pratap K. Das, Dipanjan Panda, Manish Singhal, Syed Asim Razvi, Jayanta Patowary, Shuaib Zaidi
Publikováno v:
Journal of Clinical Oncology. 38:349-349
349 Background: In a real-world scenario, Fluorouracil-based triplet combination chemotherapies have limited feasibility with regards to toxicity, need for central venous access, and hospitalization. The primary objective of this study was to assess